| Interactions between Xenobiotics and DME (XEOTIC)
|
| Fungicide(s), Herbicide(s) or Insecticide(s) |
| Pesticide/Insecticide |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| Dicrotophos |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01050
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Pesticide/Insecticide |
| DME Modulation |
Dicrotophos up-regulates the expression of DME ANPEP |
[1] |
| Health or Environmental Toxicant(s) |
| Carcinogen |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| Aflatoxin B1 |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00806
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Carcinogen-mycotoxin |
| DME Modulation |
Aflatoxin B1 inhibits the expression of DME ANPEP |
[2] |
| Pharmaceutical Agent(s) |
| Approved/Marketed Drug |
Click to Show/Hide the Full List of Xenobiotics: 15 Xenobiotics
|
| Acetaminophen |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00217
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Acetaminophen inhibits the expression of DME ANPEP |
[3] |
| Arsenic trioxide |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00339
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Arsenic trioxide inhibits the expression of DME ANPEP |
[4] |
| Aspirin |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00213
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Aspirin induces the drug-metabolizing activity of DME ANPEP |
[5] |
| Cisplatin |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00334
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Cisplatin inhibits the expression of DME ANPEP |
[6] |
| Copper sulfate |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00117
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Copper sulfate inhibits the expression of DME ANPEP |
[7] |
| Cupric chloride |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00407
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Cupric chloride inhibits the expression of DME ANPEP |
[8] |
| Cyclosporine |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00241
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Cyclosporine inhibits the expression of DME ANPEP |
[9] |
| Dasatinib |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00181
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Dasatinib inhibits the drug-metabolizing activity of DME ANPEP |
[10] |
| Decitabine |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00168
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Decitabine up-regulates the expression of DME ANPEP |
[11] |
| Diethylstilbestrol |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00166
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Diethylstilbestrol up-regulates the expression of DME ANPEP |
[12] |
| Methotrexate |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00366
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Methotrexate up-regulates the expression of DME ANPEP |
[13], [14] |
| Mifepristone |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00127
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Mifepristone inhibits the drug-metabolizing activity of DME ANPEP |
[15] |
| Troglitazone |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00086
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Troglitazone up-regulates the expression of DME ANPEP |
[16] |
| Zoledronic acid |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00140
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Zoledronic acid up-regulates the expression of DME ANPEP |
[17] |
| Rotenone |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00481
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Marketed but not Approved by US FDA |
| DME Modulation |
Rotenone up-regulates the expression of DME ANPEP |
[18], [19] |
| Drug in Phase 3 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| Fenretinide |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00565
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Highest Clinical Status: Phase 3 |
| DME Modulation |
Fenretinide inhibits the drug-metabolizing activity of DME ANPEP |
[20] |
| Preclinical/Patented Drug |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
| ICG-001 |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01336
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Patented Pharmaceutical Agent |
| DME Modulation |
ICG-001 inhibits the expression of DME ANPEP |
[21] |
| K-7174 |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01348
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Patented Pharmaceutical Agent |
| DME Modulation |
K-7174 inhibits the expression of DME ANPEP |
[22] |
| Other Chemical Compound(s) or Element(s) |
| Chemical Compound |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| 1,10-phenanthroline |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00766
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Chemical Compound |
| DME Modulation |
1,10-phenanthroline inhibits the drug-metabolizing activity of DME ANPEP |
[23] |
|
|
|
|
|
|